Atticus Wealth Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-845
Closed -$250K 182
2026
Q1
$250K Buy
845
+50
+6% +$14.9K 0.07% 161
2025
Q4
$217K Buy
795
+2
+0.3% +$543 0.05% 190
2025
Q3
$214K Buy
793
+312
+65% +$84.9K 0.05% 192
2025
Q2
$133K Buy
+481
New +$131K 0.04% 216
2024
Q2
Sell
-200
Closed -$43.1K 540
2024
Q1
$43.1K Hold
200
0.01% 260
2023
Q4
$42.1K Hold
200
0.01% 262
2023
Q3
$40K Buy
+200
New +$39.8K 0.02% 272
2021
Q3
Sell
-6
Closed -$1K 414
2021
Q2
$1K Hold
6
﹤0.01% 361
2021
Q1
$1K Hold
6
﹤0.01% 328
2020
Q4
$1K Hold
6
﹤0.01% 323
2020
Q3
$1K Sell
6
-2,403
-100% -$405K ﹤0.01% 301
2020
Q2
$392K Buy
2,409
+398
+20% +$71.3K 0.26% 57
2020
Q1
$348K Buy
2,011
+1,637
+438% +$326K 0.28% 54
2019
Q4
$75K Buy
+374
New +$76.7K 0.05% 148

Other funds holding CME

Atticus Wealth Management's CME Position: Q2 2026 in Review

Atticus Wealth Management sold out of CME Group (CME) in Q2 2026, closing a stake of 845 shares — an estimated $250K sold.

Atticus Wealth Management first reported a position in CME in Q4 2019 and held it in 14 quarters. The position peaked at $392K in Q2 2020. 222 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Atticus Wealth Management reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Atticus Wealth Management sold 845 CME Group shares in Q2 2026, an estimated $250K.
  • Atticus Wealth Management first reported a position in CME Group in Q4 2019 and held it in 14 quarters.
  • Atticus Wealth Management's CME Group position peaked at $392K in Q2 2020.
  • 222 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Atticus Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.